Mireștean, C.C.; Stan, M.C.; Schenker, M.; Volovăț, C.; Volovăț, S.R.; Iancu, D.T.P.; Iancu, R.I.; Bădulescu, F.
Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review. Diagnostics 2023, 13, 2620.
https://doi.org/10.3390/diagnostics13162620
AMA Style
Mireștean CC, Stan MC, Schenker M, Volovăț C, Volovăț SR, Iancu DTP, Iancu RI, Bădulescu F.
Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review. Diagnostics. 2023; 13(16):2620.
https://doi.org/10.3390/diagnostics13162620
Chicago/Turabian Style
Mireștean, Camil Ciprian, Mihai Cosmin Stan, Michael Schenker, Constantin Volovăț, Simona Ruxandra Volovăț, Dragoș Teodor Petru Iancu, Roxana Irina Iancu, and Florinel Bădulescu.
2023. "Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review" Diagnostics 13, no. 16: 2620.
https://doi.org/10.3390/diagnostics13162620
APA Style
Mireștean, C. C., Stan, M. C., Schenker, M., Volovăț, C., Volovăț, S. R., Iancu, D. T. P., Iancu, R. I., & Bădulescu, F.
(2023). Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review. Diagnostics, 13(16), 2620.
https://doi.org/10.3390/diagnostics13162620
